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Summary.-It has been reported that lymphocytes from cancer patients give positive
responses to PPD, myelin basic protein, tumour basic protein, and certain histone
fractions in the MEM test. The underlying mechanisms of the MEM test are poorly
understood, but it is widely assumed that it detects immunological sensitization
to specific antigenic determinants. The cross-reactivity experienced is interpreted
as indicating shared antigenicity. Since all the stimulatory proteins are strongly
basic we investigated an alternative explanation that responsiveness is a function
of electrical charge by comparing the known stimulatory proteins in the MEM
test with two others of similar basicity: lysozyme and cytochrome-C. We obtained
highly significant stimulation with PPD, tryptophane peptide of myelin, and tumour
basic protein using Mantoux + cancer patients, but found no response to other
basic proteins. We failed to confirm the reported activity of histone F2a. Our
results indicate that basicity alone is insufficient to elicit response, and strengthens
the concept that the MEM test ismeasuring sensitization to the determinants shared
by myelin and tumour basic protein.
THE macrophage electrophoretic mo-
bility (MEM) test was first suggested as
being useful in the diagnosis of human
malignant disease by Field and Caspary
(1970), and multiple sclerosis (MS) by
Field, Shenton and Joyce (1974). These
reports encouraged interest in its under-
lying mechanisms. The test is similar
in principle to the better understood
macrophage migration inhibition (MMI)
assay, in which sensitized lymphocytes
are stimulated by the appropriate antigen
to release a factor (MIF) inhibiting
macrophage migration. A similar im-
munological basis for the two tests is
suggested by their capacity to detect
lymphocyte sensitization to tumour basic
protein in cancer patients (Hughes and
Paty, 1971; Light, Preece and Waldron,
1975). The MEM test, however, is cred-
ited with greater sensitivity.
The MEM test has demonstrated
sensitization to a variety of antigens,
including the purified protein derivative
ofthe tuberculin bacillus (PPD) (Carnegie
et al., 1973b) fractionated thyroglobulin
in Graves' disease (Caspary et al., 1970),
saline extract of muscle and peripheral
human nerve in myasthenia gravis (Field
et al., 1973), encephalitogenic factor, and
human sciatic nerve basic protein in
neurological disease (Field, Caspary and
Smith, 1973). However, despite the ap-
parent specificity of these responses,
tumour basic protein will give a positive
MEM test with lymphocytes from pati-
ents suffering from demyelinating disease,
and myelin basic protein will evoke
responses with lymphocytes from pa-
tients with malignant disease. Further-
more, patients with autoimmune diseases
such as ulcerative colitis and systemic
lupus erythematosus show sensitization
to a variety of unrelated antigens, andA. SHAW, G. ETTIN AND T. A. MCPHERSON
to encephalitogenic factor and tumour
basic protein (Field, 1973). The pheno-
menon of cross-reactivity between tumour
basic protein and myelin basic protein
restricts the prognostic usefulness of the
MEM test, but also raises the question
of immunological specificity. To explain
the phenomenon within the framework
of a conventional immunological response
it was assumed that these proteins shared
antigenic determinants. Three lines of
evidence for shared determinants have
been cited. Coates and Carnegie (1975)
found that lymphocytes from guinea-pigs
injected with tumour basic protein showed
significant transformation on exposure to
myelin basic protein. Field, Caspary and
Carnegie (1971) showed that serotonin
could competitively inhibit stimulation
by tumour basic protein, myelin basic
protein and PPD. McDermott, Caspary
and Dickinson (1974) covalently bound
the three antigens to solid supports, and
demonstrated that on performing cellular
affinity chromatography, each antigen
could significantly reduce responsiveness
to the other two, using lymphocytes
from MS or cancer patients. However,
it appeared unlikely to us that all three
protein preparations shared antigenic de-
terminants. We felt a simpler explana-
tion for their cross-reactivity was sug-
gested by the finding of Johns et al.
(1973) that histone fractions 2a1, 2a2, 1,
and 3 gave marked slowing of macro-
phages following incubation with a cancer
patient's lymphocytes. Since these are
all basic proteins we postulated that
response in the MEM test might be a
function of the electrical charge of the
protein rather than its antigenic pro-
perties. To test this hypothesis further,
we compared the response of lymphocytes
from patients with malignant melanoma
to stimulation by tumour basic pro-
tein, the encephalitogenic nonapeptide of
myelin basic protein, and four un-
related proteins of comparable basi-
city. One acidic protein, human serum
albumin, was included as a negative
control.
MATERIALS AND METHODS
Lymiphocytes.-Peripheral blood lympho-
cytes were obtained from healthy normal
volunteers and patients with neoplastic
disease. Heparinized whole blood (sodium
heparin 140 iu/10 ml) was layered over
Ficoll-Hypaque (specific gravity 1-077), and
the lymphocyte-enriched interface recovered
after centrifugation (500 g, 20 min). The
cells were washed three times in Dulbecco's
phosphate buffered saline pH 7-4 (PBS),
and resuspended in PBS to a final concentra-
tion of 106 cells/ml. Differential staining
of the resulting preparation showed that
70-80% of the cells were lymphocytes, the
remainder being monocytes and granulocytes.
Macrophages.-Normal guinea-pig macro-
phages w%rere produced by i.p. injection of
25-30 ml of sterile, warm, light mineral oil
(Mallinckrodt, U.S.A.) into Camm-Hartley
strain guinea-pigs (Jackson Laboratories) of
either sex, weighing in excess of 300 g.
The guinea-pigs were maintained in pairs
in closed colonies. No special precautions
were taken to avoid infections but only
healthy-looking guinea-pigs were used. These
were sacrificed from 7-14 days post-injection
by ether anaesthesia, and the peritoneal
exudate harvested by lavaging with 100 ml
of PBS containing 5 iu ofsodium heparin/ml.
The peritoneal exudate cells were washed
three times with PBS by centrifugation at
250 g to remove mineral oil. Red blood
cells were lysed by osmotic shock with
distilled water. The macrophage-rich sus-
pension was adjusted to a final concentration
of 3 x 106 cells/ml and irradiated with 200 R
from a 137Cs source.
Antigen source. The following antigens
were used:
PPD: soluble lyophilized form (Parke-Davis,
U.S.A.).
Tryptophane peptide: synthetic encephalito-
genic peptide derivative of myelin basic
protein (Beckman, U.S.A.).
Cytochrome C: basic protein (Sigma Chemical
Co., U.S.A.).
Lysozyme: basic protein (Sigma Chemical
Co., U.S.A.).
Human gamma globulin: (Nutritional Bio-
chemicals Corporation, U.S.A.).
Tumour basic protein: crude acid extract
obtained from metastatic liver (primary
carcinoma of colon) prepared by the
method of Dickinson, Caspary and Field
(1973).
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Histone: basic protein fraction 2a (Worthing-
ton Biochemical, U.S.A.).
Human serum albumin: acidic protein frac-
tion 5 (Nutritional Biochemicals Cor-
poration, U.S.A.).
Human serum albumin has an isoelectric
point (pl) of 4-8, human gamma globulins
range between 6-6 and 7-2, whereas lysozyme
has a pl of 11-0, and cytochrome-C of 10-5
(Lehninger, 1972). Preparations of tumour
basic protein contain more than one com-
ponent on gel electrophoresis. However,
the component containing the antigenic
properties has an electrophoretic mobility
0 85 that of cytochrome-C on poly-
acrylamide gel electrophoresis (Caspary,
1973). The pls of tumour basic protein,
and myelin basic protein have yet to be
assessed, but their electrophoretic mobilities
relative to cytochrome-C, and their elution
characteristics from CM-cellulose suggest
that tumour basic protein is strongly basic,
but not as extremely basic as myelin basic
protein (Dickinson, et al., 1974). The pl of
myelin basic protein is above 10-6 whereas
tumour basic protein is less basic than
THE MEM TEST
CONTROL | TEST
Peripheral blood lymphocyte
(F/H Separated)
INCUBATION 90min.
at 23°C
Guinea Pig Macrophage
(200R)
INCUBATION 90mi.
at 37°C
NORMAL MOBILITY REDUCED MOBILITY
FIG. 1. Diagrammatic representation ofincuba-
tion proce(ldre. Ag -antigen. F/H = Ficoll-
Hypaque. MEM -Macrophage electro-
phoretic mobility.
cytochrome-C, and its electrophoretic mo-
bility is very similar to that of histone
(Deibler, Martenson and Kies, 1972).
Incubation of lymphocytes and macro-
phages.-Incubations were performed accord-
ing to the MOD-MEM split incubation
technique of Pritchard et al. (1973) with
one major modification. In our protocol,
control supernatants wTere reconstituted with
a concentration of antigen equivalent to
the experimental supernatant, prior to in-
cubation with the macrophages. One ml
of a lymphocyte suspension, containing 106
cells, was incubated with 30 [kg of the
appropriate antigen in a final volume of
1-2 ml for 90 min at 23°C in the experimental
tube, and the lymphocytes were incubated
for a similar period without antigen in
the control. The cells were spun at 250gq
for 10 min, the supernatants pipetted off,
the control supernatant reconstituted with
antigen, and then stored at -80°C. Five ml
of the macrophage suspension was incubated
with one ml of the experimental and control
supernatants, respectively, for 90 min at
37°C. By separating the incubation of
lymphocytes from that of the macrophages
any possibility of stimulation arising from
mixed lymphocyte reactions is obviated.
The methodology is presented diagram-
matically in Fig. 1.
Cytopheromneter.-Measurements of macro-
phage electrophoretic mobility were per-
formed in a cytopherometer (Ranks Bros.,
Cambridge, England). The cylindrical capil-
lary chamber was employed, and maintained
at a constant temperature of 23°C. A
potential difference of 40 V was applied
across the electrodes giving a current of
2 mA in PBS. Blacked platinum electrodes
were used.
Measurements.-Following incubation of
the macrophages with the lymphocyte-
antigen supernatants, they were transferred,
suspended in the incubation mixture, to
the cytopherometer. Cells were selected
from the heterogeneous macrophage popula-
tion on the basis of appearance. Only
cells with 2-4 oil droplets were followed,
adhering to the criteria defined by Shenton,
Hughes and Field (1973). The time taken
for the selected cell to traverse 32 ,u in the
stationary layer was recorded using a stop-
watch. Each cell was timed in both direc-
tions by reversing the polarity, and readings
discarded if there was more than 10%
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discrepancy between the members of each
pair (Pritchard et al., 1972).
The response of the macrophages was
checked in each experiment by the inclusion
of a supernatant obtained by incubating
PPD with a PPD-+ donor's lymphocytes
as a positive control. The 00 reduction
in mobility was calculated according to the
formula used by Field et al. (1973).
If
tp = migration time with no antigen
present in the lymphocyte control
incubation
and
tc = migration time in the presence of
antigen in the lymphocyte experi-
mental incubation
then
tc x 100
is the percentage slowing of the macro-
phages attributable to factor(s) released by
lymphocytes in the presence of antigen.
Because all supernatants contain antigen,
the influence of antigen alone on macrophage
mobility is controlled. In practice, the
control supernatants consistently failed to
influence the mobility of the macrophage
from its normal value, suggesting that, at
the antigen concentration employed, tl-he
influence of antigen is negligible. All super-
natants were coded, and the test performed
in a double-blind manner to prevent operator
bias.
RESULTS
A total of 8 patients suffering from
malignant melanoma were tested for
response to the test antigens. Each
patient was tested on several occasions,
and Mantoux normal volunteers
included as controls. All patients were
Mantoux +. On average, 20 cells from
each incubation mixture were timed in
both directions: control timings were
typically 5-71 + 0-11 s (mean ± s.d.) for
32 ,u displacement. The presence of anti-
gen made no significant difference to
macrophage mobility. E.g. control super-
natant + tryptophane peptide, 5 78±0- 11
s; + tumour basic protein, 5-81 ± 0 09 s,
and + histone, 5-81 i 0-09 s. A scatter-
gram showing the pooled results is pre-
sented in Fig. 2. Cancer patients con-
sistently responded to PPD, tumour basic
protein, and the tryptophane peptide of
myelin basic protein, whereas Mantoux-
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0
0
0000 00
0 0 Y..
- A TUMOUR PATIENTS ' NORMALS.A
MEAN 9.4 9.2 5.9 0.3 0.6 -0.1 -0.6 -0.4 0.8 1.2
S.D. ±4.8 ±4.6 ±34 ±2.5 ±1.2 ±1.3 ±1.1 ±0.6 ±1.7 ±1.6
Fi(.. 2. Scattergram showing pooledl respons.s of lymphocytes of tumour patients and(t iiormals
to stimulation by antigens as measured in MEM test. Arithmetic means and standard (leviations
are presented beneath each group. Abbreviations for antigens: PPD purified protein derivative
of tuberculin; TRYP tryptophane peptide of myelin basic protein; TBP tumour basic protein;
HSA human serum albumin; HIS-histone fraction 2a; LYS lysozyme; CYT cytochrome-C;
HGG-human gamma globulin.
20
15
o 10
z
-J
en
0-0
-5
IC)
-
a
.00
00
0
00
0RESPONSES OF CANCER PATIENTS IN THE MEM TEST
normals did not. Cancer patients failed
to respond to the basic proteins histone
fraction 2a, lysozyme, cytochrome-C, and
human gamma globulin, or to the acidic
protein control, human serum albumin.
DISCUSSION
Our results clearly indicate that re-
sponse in the MEM test cannot be con-
sidered solely a function of the electrical
charge of the test antigen, since the
strongly basic proteins lysozyme, cyto-
chrome-C, and histone are ineffective.
The failure of histone fraction 2a to
elicit positive responses with cancer pa-
tients' lymphocytes is surprising since
Johns et al. (1973) found that histone
fraction 2, subfractions a1 and a2, pro-
duced considerable slowing. Indirect evi-
dence, in support of Johns' data, has
been recently provided by Sabolovic et
al. (1975) who showed that massive
agglutination of cancer patients' lympho-
cytes occurred in the presence of histone
fraction 2a1, but that lymphocytes from
normal volunteers were unaffected. How-
ever, conflicting information has been
published by Schmid et al. (1974) who
were unable to demonstrate immuno-
logical cross-reactivity between histone
fractions 1, 2a1, 2a2, and 3 to antibodies
directed against human myelin basic
protein. Although the lack of cross-
reactivity of the histone fractions to
antibodies directed against myelin basic
protein supports our findings, it has
been argued that T-cell receptors may
not recognize the same determinants as
B-cell immunoglobulins (Diener and Lang-
man, 1975). Since MIF/MEM activity
is considered a T-cell response, this
cannot be cited as definitive proof of
the absence of shared determinants.
McDermott et al. (1974) used unfrac-
tionated calf thymus histone as a control
basic protein in their cellular affinity
studies, and reported that it was unable
to deplete lymphocytes responsive to
tumour basic protein and myelin basic
protein. More compelling evidence for
a lack of cross-reactivity between histone
fraction 2 and myelin basic protein is
provided by the work of Coates and
Carnegie (1975). They showed that the
histone fraction was unable to elicit
transformation of guinea-pig lymphocytes
sensitized to tumour basic protein al-
though tumour and myelin basic protein
would produce significant transformation.
It is difficult to reconcile these conflicting
reports, but variation in the composition
and purity of the histone fraction could
account for some non-reactivity since
some histone fractions are relatively
inactive (Johns et al., 1973). Previous
reports (e.g. Whittingham et al., 1972)
of antibodies to myelin basic protein
cross-reacting with histones probably re-
flect the degree of histone contamination
in the immunizing protein rather than
antigenic identity. Strong evidence in
support of the contention that basicity
is not the only requirement for activity
is our finding that the tryptophane
peptide of myelin is effective in producing
positive responses with cancer patients.
The tryptophane peptide derivative of
myelin basic protein is neutral at physio-
logical pH, but still retains the stimulatory
activity of the parent basic protein. In
this context, further evidence that an
immunological recognition event is operat-
ing independently of electrical charge
is provided by Carnegie, Caspary and
Field (1973a) who showed that blocking
tryptophane activity of myelin basic
protein with Koshland's reagent markedly
reduced its effectiveness in the MEM
test without affecting the overall charge.
The inactivity of basic proteins other
than myelin and tumour basic protein
in the MEM test does not pre-empt a
function for charge effects in lymphocyte-
antigen recognition, but indicates that
antigenic specificity plays a determining
role. That charge effects may be impor-
tant in T-cell recognition of antigens is
indicated by the recent report of Teitel-
baum et al. (1975), who showed that
thymocytes with specificity for negatively
charged antigens could be depleted on
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positively charged columns, and vice
versa. These investigators found that
the thymocytes depleted on the columns
performed the full range of T-cell func-
tions, including T helper-cell cooperation
and cell-mediated immune responses of
the delayed hypersensitivity type. In
conclusion, our finding that basic proteins,
other than tumour basic protein, and
the tryptophane peptide of myelin basic
protein were unable to elicit positive MEM
responses strengthens the concept that
the test is monitoring an antigenic
recognition event, and enhances its vali-
dity as a sensitive indicator of immune
response to tumour antigens.
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